Tıp Eğitimi: Ege Üniversitesi Tıp Fakültesi, İzmir, Türkiye, 2006-20012

Psikiyatri Asistanlığı: Celal Bayar Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı Manisa, Türkiye (Kasım 2012 - Kasım 2016)

Psikiyatri Uzmanlığı: Kasım 2016- Ekim 2021

Psikiyatri Doçentliği: 2021 yılı Ekim’den bu yana devam etmekte

Eylül 2020- …: Türkiye Psikiyatri Derneği Genç Psikiyatristler Komitesi, Yönetim Kurulu Üyesi

ULUSLARASI ve ULUSAL BİLİMSEL YAYINLAR

1. Çökmüş, F. P., Aydın, O., Balıkçı, K., & Ünal-Aydın, P. (2022). The excessive utilisation of social networking sites affects the symptom severity across patients with anxiety disorders. International Journal of Mobile Communications, 20(4), 406-418.
2. Cokmus FP, Ascibasi K, Suculluoglu Dikici D, Coldur EO, Avci E, Aydemir O. Seasonality in Bipolar Disorder: Impact on Mood Symptoms, Psychosocial Functioning, Neurocognition, and Biological Rhythm. Archives of Neuropsychiatry. 2021; 58(1):41. doi: 10.29399/npa.25056
3. Çökmüş, F. P., Özkan, H. M., Sücüllüoğlu-Dikici, D., Aşçibaşi, K., Alçi, D., Altunsoy, N., ... & Aydemir, Ö. The Assessment of Cognitive Dysfunction in Major Depressive Disorder: A 16-Week Prospective Case-Control Study. Psychiatry and Clinical Psychopharmacology 2021;31:25-33.
4. Altunsoy, N., Di̇ki̇ci̇, D. S., Çökmüş, F. P., Özkan, H. M., Aşçibaşi, K., Alçi, D., ... & Aydemi̇r, Ö. (2021). Evaluation of psychosocial functioning in the acute treatment term of major depressive disorder: A 16-week multi-centered follow-up study. Asian Journal of Psychiatry, 66, 102883.
5. Başer, L. M., Çökmüş, F. P., Tvrtković, S., Obuća, F., Ünal-Aydın, P., Aydın, O., & Spada, M. M. (2022). The role of desire thinking in the problematic use of social networking sites among adults. Addictive Behaviors Reports, 100463.
6. Aydin, O., Çökmüş, F. P., Balikçi, K., Sücüllüoğlu-Dikici, D., & Ünal-Aydin, P. (2020). The problematic use of social networking sites associates with elevated symptoms in patients with major depressive disorder. International Journal of Social Psychiatry, 0020764020919791.
7. Çökmüş, F. P., Özmen, E., Alkin, T., Batir, M. B., & Çam, F. S. (2018). Evaluation of serum MicroRNA expression profiles in patients with panic disorder. Psychiatry and Clinical Psychopharmacology, 1-6.
8. Aşçibaşi K, Çökmüş FP, Dikici DS, Özkan HM, Alçi D, Altunsoy N, Kuru E, Yüzeren S, Aydemir Ö. Evaluation of Emotional Adverse Effects of Antidepressants: A Follow-up Study. J Clin Psychopharmacol. 2020, 40(6), 594-598.doi: 10.1097/JCP.0000000000001300.
9. Aydın, O., Balıkçı, K., Çökmüş, F.P., Ünal-Aydın, P., 2019. The evaluation of metacognitive beliefs and emotion recognition in panic disorder and generalized anxiety disorder: effects on symptoms and comparison with healthy control, Nordic Journal of Psychiatry, DOI: 10.1080/08039488.2019.1623317
10. Çökmüş FP, Aydın O, Balıkçı K, Ünal-Aydın P. The excessive utilization of social networking sites affects the symptom severity across patients with anxiety disorders. International Journal of Mobile Communication
11. Cokmus FP, Aydın O, Balikci K, Unal Aydin P, Esen Danaci A. The examination of the oxytocin and vasopressin effects on social functioning among individuals with schizophrenia. European Neuropsychopharmacology 2020; 31: 56-57.
12. Aydemir, Ö., Çökmüş, FP., Akdeniz, F., Dikici, DS., & Balıkçı, K. Psychometric properties of the Turkish Versions of Perceived Deficit Questionnaire-Depression and British Columbia Cognitive Complaints Inventory. Anatolian Journal of Psychiatry.
13. Sücüllüoğlu Dikici, D., Eser, E., Çökmüş, F. P., & Demet, M. M. (2018). Quality of Life and Associated Risk Factors in Caregivers of Patients with Obsessive Compulsive Disorder. Psychiatry and Clinical Psychopharmacology, 1-8.
14. Suculluoglu Dikici D, Çökmüş FP, Akın F, Eser E, Demet MM. Disease burden and ssociated factors in caregivers of patients with obsessive-compulsive disorder. Neurological Sciences, 2020.  DOI: 10.147444/DAJPNS.2020.00111.
15. Çökmüş, FP., Aşçıbaşı, K., Öztekin, S., & Demet, MM. (2017). Relationship of levetiracetam and obsessive-compulsive disorder: a case report. Psychiatry and Clinical Psychopharmacology, 27(3), 325-327.
16. Aydin, O., Balikci, K., Tas, C., Unal Aydin, P., Cokmus, F. P., & Esen Danaci, A. (2017). The comparison of executive functions, social cognition and plasma oxytocin level between mothers' of schizophrenia patients and healthy control: searching for a new endophenotype. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 18(4), 307-313.
17. Cokmus FP, Balikci K, Aydemir O, GRUBU DOC. [Reliability and validity of Turkish Form of DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Scale-Adult Version]. Anadolu Psikiyatri Derg. 2017; 18(Supplement 2): 5-12.
18. Ascibasi K, Cokmus FP, Aydemir O, Grubu DOC. [Reliability and validity of Turkish Form of Severity of Acute Stress Symptoms Scale]. Anadolu Psikiyatri Derg. 2017; 18(Supplement 2): 38-44.
19. Aydin O, Cokmus FP, Aydemir O, Grubu DOC. [Validity and reliability of the Turkish Version of the Clinician Rated Severity of Autism Spectrum and Social Communication Disorders Scale]. Anadolu Psikiyatri Derg. 2017; 18(Supplement 2): 92-98
20. Aydin, O., Çökmüş, F. P., Balikçi, K., Aydin, P. Ü., & Danaci, A. E. (2018). Şizofreni hastalarının bakım verenlerinde sosyal anksiyete, saldırganlık ve bağlanma stilinin hastalık şiddeti üzerine etkisi. Anadolu Psikiyatri Dergisi, 19(3), 274-280.
21. Çökmüş, FP., Aşçıbaşı, K., Sarıkavak, T., & Özmen, E. (2016). Psychotic disorder secondary to systemic corticosteroids. Anatolian Journal of Psychiatry, 17(1), 74-76.
22. Çökmüş, FP., Aydın, O., Sücüllüoğlu Dikici, D., & Yalın Sapmaz, Ş. (2017). Quickly diagnosed and treated prepubertal Type 1 narcolepsy case. Psychiatry and Clinical Psychopharmacology, 1-3.
23. Asik EA, Cokmus FP, Aydemir O, Grubu DOC. [Reliability and validity of Turkish Form of Level 2 Anxiety Scale]. Anadolu Psikiyatri Derg. 2017; 18(Supplement 2): 45-50. Turkish. doi:10.5455/apd.240513
24. Çöldür EÖ, Çökmüş FP, Sücüllüoğlu-Dikici D, Aydemir Ö. (2020) The validity and reliability of DSM-5 separation anxiety disorder severity scale-adult form. The Journal of Psychiatry and Neurological Sciences.
25. Taşkın EO, Aşçıbaşı K, Çökmüş FP, Özmen E. Attitudes of Resident Physicians Working in a University Hospital Towards Schizophrenia. Psychiatry and Behavioral Science. 2019: 9(4). DOI: 10.5455/PBS.20190513032606
26. Turkmen, S. N., Ustun, C., Ozdemir, C., Akyol, T., & Cokmus, F. P. (2017). Health professionals’ exposure to mobbing in a medical school hospital. Journal of Turgut Ozal Medical Center, 24(4).

BAZI POSTER BİLDİRİLERİ:

1. Çökmüş FP, Ascibasi K, Oztekin S, Demet MM. Levetirasetam ve Obsesif Kompulsif Bozukluk İlişkisi: Bir Olgu Sunumu, TPD 18. Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Nisan, 2014, Antalya, Türkiye
2. Çökmüş FP, Coldur EO, Balikci K, Sarikavak T, Herdem A, Ascibasi K, Akdeniz K, Suculluoglu Dikici D, Alci D, Yüzeren S, Öztekin S, Aydın Aşık E, Aydın O, Köroğlu E, Aydemir Ö. Erişkin Ayrılma Anksiyetesi Bozukluğunun Türkçe Geçerlilik Güvenilirliği, TPD 20. Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Mayıs 2016, İzmir, Türkiye.
3. Cokmus FP, Ascibasi K, Ozmen E, Taskin EO. Bir Üniversite Hastanesinde Çalışan Asistanların Depresyona Yönelik Tutumlarının Araştırılması, 51. Ulusal Psikiyatri Kongresi, Kasım, 2016, Antalya, Türkiye.
4. Cokmus, FP, Ascibasi K, Sarikavak T, Ozmen E. Sistemik Kortikosteroid Kullanımına İkincil Psikotik Bozukluk Gelişimi. 7. Ulusal Anksiyete Kongresi, Eylül, 2014, Girne, Kuzey Kıbrıs.
5. Cokmus FP, Ozmen E, Batır MB, Alkin T, Çam FS. Evaluation of serum miRNA expression profile in panic disorder patients. EPA 2017 25^th European Congress of Psychiatry, Florence, Italy.
6. Cokmus FP, Yalın Sapmaz Ş. Bir Yıl Sonra Tanısı Netleşen Tip 1 Narkolepsili Çocuk Olgu. 53. Ulusal Psikiyatri Kongresi, 2017, Bursa, Türkiye.
7. Cokmus FP, Suculluoglu Dikici D, Akarsu E, Taskin EO. Bir Şizofreni Hastasında Genital Self Mutilasyon: Olgu Sunumu. 53th The National Congress of Pyschiatry Association of Turkey, 2017, Bursa, Turkey.
8. Cokmus FP, Suculluoglu Dikici D. A Schizophrenic Patient Who Drinks 40 Litres Water Per a Day. 10. Ulusal Anksiyete Kongresi &3. Psikiyatri Zirvesi, Mart 2018, Antalya, Türkiye.
9. Cokmus FP, Yuzeren S, Suculluoglu Dikici D, Aydın O, Unal Aydın P, Akdeniz F, Oztekin S, Coldur EO, Balikci K, Korouglu E, Aydemir O. Reliability and Validity of Turkish Form of The Personality Inventory for DSM-5 (PID-5) Adult Version. EPA 2018 26^th European Congress of Psychiatry, Nice, France.
10.  Suculluoglu Dikici D, Eser E, Cokmus FP, Demet MM. Caregiver Burden and Associated Risk Factors in Relatives of Patients with Obsessive Compulsive Disorder. EPA 2018 26^th European Congress of Psychiatry, Nice, France.
11.  Suculluoglu Dikici D, Cokmus FP. Amitriptilinle Tedavi Edilen Bruksizm Hastası. 10. Ulusal Anksiyete Kongresi &3. Psikiyatri Zirvesi, Mart 2018, Antalya, Türkiye.
12.  Kabadayı Alçı D, Çökmüş FP, Altunsoy N, Ascibasi K, Ozkan HM, Suculluoglu Dikici D, Yuzeren S, Aydemir O. Evaluation of Psychosocial and Neurocognitive Functioning in the Acute Treatment term of Major Depressive Disorder. ECNP 2019, Kopenhag, Denmark. 

ÖDÜLLER ve BURSLAR:

1. European Psychiatric Association (EPA) Early Career Psychiatrist Scholarship Programme (ECP) 2021
2. ECNP School of Neuropsychopharmacology for Early Career Psychiatrist, Oxford, 2021.
3. ECNP Research Internship Programme, 2019, Groningen Institute for Evolutionary Life Sciences, Groningen University, Hollanda.
4. ECNP Workshop for Early Career Scientists in Europe, 5-8 Mart 2020, Nice, Fransa.
5. Cokmus FP, Uluçay S, Ozmen E, Batır MB, Alkin T, Çam FS. Evaluation of serum miRNA expression profile in panic disorder patients. TPD 20.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Mayıs 2016, İzmir, Turkey. Araştırma Proje Teşvik Ödülü.
6. Cokmus FP, Ozmen E, Batır MB, Alkin T, Çam FS. Panik Bozukluğu Tanılı Hastalarda Serum miRNA Ekspresyon Profillerinin İncelenmesi. 9. Ulusal Anksiyete Kongresi & 2. Psikiyatri Zirvesi, Mart 2017, Antalya, Türkiye. Genç Araştırmacı Özel Ödülü.
7. Cokmus FP, Ascibasi K, Suculluoglu Dikici D, Coldur EO, Avci E, Aydemir O. Bipolar Bozukluk Tanılı Hastalarda Mevsimselliğin Belirti Örüntüsü ve İşlevsellik Üzerine Etkisi: TPD 22.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, 2018, Antalya, Türkiye. Araştırma Proje Teşvik Ödülü.
8. Aydın O, Esen Danacı A, Sarandöl A, Aydemir Ö, Kocabaş T, Çökmüş FP, Balıkçı K, Onur E, Taştan İ. The comparison of levels of plasma zonulin between healthy controls and schizophrenic/bipolar disorder patients. 15-16 Eylül, İzmir, Türkiye. Bipolar Bozukluklar Araştırmacı ve Klinisyen Eğitimi (BAKET), Araştırma Projesi Teşvik Ödülü.

KİTAP BÖLÜMÜ YAZARLIĞI:

1. Çökmüş FP, 2019. Duygudurum ve Anksiyete Bozukluklarının Kardiyovasküler Etkileri. Akademisyen Kitabevi,1149-1156.

KONGRELERDE PANEL KONUŞMALARI: 

1. Sosyal medya kullanımının Anksiyeteye Etkisi. 58. Ulusal Psikiyatri Kongresi, İzmir, 2022, Türkiye
2. Panik Bozuklukta Nörobiyolojiden Tedaviye. 1. Uluslararası & 25. Klinik Eğitim Sempozyumu. Çeşme, 2022, Türkiye.
3. Ruh Sağlığı Hastanesinde Şizofreniye Yaklaşım: Tedaviye Dirençli Vakalar. 6. Psikiyatri Zirvesi & 13. Anksiyete Kongresi. Antalya, 2021, Türkiye
4. Bilimsel Çalışma Yönetirken ‘Yeni Normaller’. Türkiye Psikiyatri Derneği 24. Klinik Eğitim Sempozyumu, 2021.
5. Erişkin Dönemde Otizm Spektrum Bozukluğu ve Anksiyete Birlikteliğinde Klinik Görünüm, Tedavi Yöntemleri, 5. Psikiyatri Zirvesi & 12. Anksiyete Kongresi, 2020.
6. Depresyon Tedavisinde Ne Kadar Başarılıyız? Çok Merkezli Bir Çalışmanın Tartışılması: Akut Dönemin Zor Tedavi Edileni: Bilişsel Belirtiler. 55. Ulusal Psikiyatri Kongresi, İstanbul 2019, Türkiye.
7. Genç Uzman Gözünden Poliklinik Şartlarından Bipolar Bozukluğu Her Yönüyle Ele Almak: Mevsimselliği Değerlerdirmek. TPD 23.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Fethiye, 2019, Türkiye.
8. Bipolar Bozuklukta Oksidatif Stres ve İnflamasyon: Kognitif Fonksiyonlar Konusunda Bize Ne Diyor? 54. Ulusal Psikiyatri Kongresi, İzmir, 2018, Türkiye
9. Anksiyete Bozuklukları ile Eştanılı Tıbbi Durumlarda Tanı ve Tedavi Yaklaşımları: Kalp Damar Hastalıkları ve Anksiyete Bozuklukları. TPD 22.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Antalya 2018, Türkiye.
10. Panik Bozukluğunda Tanısal Değerlendirme ve Yeni Tedavi Seçenekleri.  53. Ulusal Psikiyatri Kongresi, 2017, Bursa, Türkiye.
11. miRNAlar ve Anksiyete Bozuklukları İlişkisi. TPD 21.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, 2017, Antalya, Türkiye.
12. Şizofrenide miRNA Çalışmaları. 53. Ulusal Psikiyatri Kongresi, 2017, Bursa, Türkiye.

SÖZEL BİLDİRİLER:

1. Şizofreni hastaları ve Hasta Olmayan Birinci Derece Akrabalarında Mitokondriyal Dna Polimorfizmlerinin İncelenmesi. TPD 21.Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, 2017, Antalya, Türkiye.
2. DSM-5 Kişilik Envanteri Erişkin Formunun Türkçe Geçerlilik ve Güvenilirliği (PID-5). 10^th International Congress on Psychopharmacology&6^th International Symposium on Child and Adolescent Psychopharmacology, 2018, Antalya, Türkiye
3. Bipolar Bozukluk ve Sağlıklı Kontrollerde Mevsimsellik: Psikososyal İşlevselliğe Etkisi. 6. SAYKAD Sağlıkta Yaşam Kalitesi Kongresi, İzmir, 2019, Türkiye.
4. Bipolar Bozukluk Hastalarında Mevsimsellik: Psikososyal İşlevselliğe Etkisi. 6. SAYKAD Sağlıkta Yaşam Kalitesi Kongresi, İzmir, 2019, Türkiye.
5. Major Depresif Bozuklukta İlaç Tedavisinin Psikososyal İşlevselliğe Etkisi. 6. SAYKAD Sağlıkta Yaşam Kalitesi Kongresi, İzmir, 2019, Türkiye.

DERGİ EDİTÖRLÜĞÜ

1.The Inflammation Markers in Schizophrenia and Bipolar Disorder: Do We Have Promising Results? (2022) Frontiers in Psychiatry.

ULUSLARARASI DERGİLERDE HAKEMLİK DENEYİMLERİ

1.Cyberpsychology, Behavior, and Social Networking (9 kez)

1. International Journal of Psychiatry in Clinical Practice (4 kez)
2. The International Journal of Psychiatry in Medicine (1 kez)
3. BMC Pediatrics (1 kez)
4. Psychiatria Danubina (1 kez)
5. Annals of Clinical and Analytical Medicine (2 kez)
6. Alpha Psychiatry (1 kez)
7. Journal of Clinical Psychiatry (1 kez)
8. Cukurova Medical Journal (2 kez)

​

The Associations between Mindfulness, Metacognition and HbA1c Levels Among Diabetic Pregnant Patients: a Case Control Study

By

Gölbasi, C (Golbasi, Ceren) [1] ; Cökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Baser, LM (Baser, Lejla Mustoo) [3] ; Gölbasi, H (Golbasi, Hakan) [4] ; Aydin, PÜ (Aydin, Pinar Unal) [3] ; Orkun, A (Orkun, Aydin) [3]

 (provided by Clarivate) 

Source

PSIHOLOGIJA

Volume

58

Issue

2

Page

193-209

DOI

10.2298/PSI230222013G

Published

2025

Indexed

2025-04-05

Document Type

Article

Abstract

Pregnancy, due to the diversity of lifestyle changes it leads to, may represent a period characterized by intensified stress. Women of childbearing age are at the highest risk for a number of health difficulties and complications, including glucose abnormalities. Such an occurrence often has a set of complex consequences for both the mother and the newborn. We aimed to examine how mindfulness and metacognition interact with HbA1c levels during pregnancy characterized by Gestational diabetes mellitus (GDM). One hundred pregnant women with GDM and ninety-eight healthy pregnant women were enrolled in the study. Average blood glucose levels were assessed by HbA1c monitoring. Participants completed the Hospital Anxiety and Depression Scale (HADS), DSM-5 Level 2-AnxietyAdult measure (DSM-5 Anxiety), Five-Facet Mindfulness Questionnaire (FFMQ), and Metacognition Questionnaire-30 (MCQ-30). A negative correlation was found between HbA1c and FFMQ "Describing" subtest, while a positive correlation was obtained between HbA1c and MCQ-30 "Negative beliefs about uncontrollability and danger" subtest. Multiple linear regression showed an association between Mindfulness Describing subtest and HbA1c as an outcome variable. Findings imply the association between mindfulness and HbA1c during pregnancy period. Mindfulness cultivation seems to be relevant in emotional and cognitive processes in order to minimize negative stress related effects on well- being during pregnancy. Such approach may be beneficial in promoting treatment compliance among pregnant women with diabetes, but also among women experiencing low prenatal well- being.

Keywords

Author Keywords

pregnancy mindfulness metacognition glucose abnormalities gestational diabetes mellitus
 

The excessive utilisation of social networking sites affects the symptom severity across patients with anxiety disorders

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Aydin, O (Aydin, Orkun) [3] ; Balikçi, K (Balikci, Kuzeymen) [2] ; Ünal-Aydin, P (Unal-Aydin, Pinar) [3]

 (provided by Clarivate) 

Source

INTERNATIONAL JOURNAL OF MOBILE COMMUNICATIONS

Volume

20

Issue

4

Page

406-418

DOI

10.1504/IJMC.2022.123774

Published

2022

Indexed

2022-07-12

Document Type

Article

Abstract

Despite the well-known undesired effects of problematic social networking sites (SNSs) use, the studies performed with the psychiatric population are still scarce. The objective of this research is to discover whether problematic SNS use affects symptom severity among patients with anxiety disorder (AD). One-hundred patients with AD and 100 healthy controls (HCs) participated. State-trait anxiety inventory (STAI) and social media addiction scale (SMAS) were administered. In order to reveal the associations between SNSs use and anxiety symptoms, Pearson correlations and linear regression analyses were performed. According to our results, the state and trait anxiety were positively correlated with virtual communication scores among AD patients. HCs' trait anxiety was associated with both SMAS subtests; however, the state anxiety was not in a relationship with problematic SNSs use. Our study demonstrated the negative effects of problematic SNS use on AD. The clinicians should consider SNSs use patterns while managing the treatment of AD.

Keywords

Author Keywords

addictionanxiety disorder excessive use social networking sites SNSs state anxiety trait anxiety

The role of desire thinking in the problematic use of social networking sites among adults

By

Baser, LM (Baser, Lejla Mustoo) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Tvrtkovic, S (Tvrtkovic, Selma) [1] ; Obuca, F (Obuca, Faruk) [1] ; Ünal-Aydin, P (Unal-Aydin, Pinar) [1] ; Aydin, O (Aydin, Orkun) [1] ; Spada, MM (Spada, Marcantonio M.) [3]

 (provided by Clarivate) 

Source

ADDICTIVE BEHAVIORS REPORTS

Volume

16

DOI

10.1016/j.abrep.2022.100463

Article Number

100463

Published

DEC 2022

Indexed

2022-12-01

Document Type

Article

Abstract

The problematic use of social networking sites (SNS) is associated with several psychiatric disorders. This behavior closely resembles addiction in terms of neurological basis and behavioral patterns. Nevertheless, successful intervention strategies and the etiology of problematic SNS use are not yet thoroughly investigated. We aimed to study whether desire thinking is associated with problematic SNS use among adults when controlling for some confounders, including boredom, affect, and impulsivity. With the help of convenience sampling, we enrolled 546 Turkish adults in this study to whom we administered a sociodemographic form, the Social Media Addiction Scale (SMAS), the Leisure Boredom Scale (LBS), the Positive and Negative Affect Schedule (PANAS), the Barratt Impulsiveness Scale (BIS-11), and the Desire Thinking Questionnaire (DTQ). To explore the association between the variables, we performed Pearson correlational and hierarchical regression analyses. The results showed that higher scores on two sub-dimensions of desire thinking, namely verbal perseveration and imaginal prefiguration, were associated with higher scores on problematic SNS use after we controlled for boredom, affect, and impulsivity. This study demonstrates that desire thinking may play a role in problematic SNS use among adults. We recommend targeting desire thinking as a potential area in treatments which may help alleviate problematic SNS use.

Keywords

Author Keywords

Problematic SNS use Desire thinking Boredom Impulsivity Affect

Seasonality in Bipolar Disorder: Impact on Mood Symptoms, Psychosocial Functioning, Neurocognition, and Biological Rhythm

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Asçibasi, K (Ascibasi, Kadir) [2] ; Süçüllüoglu Dikici, D (Suculluoglu Dikici, Didem) [1] ; Çöldür, EÖ (Coldur, Emine Ozge) [3] ; Avci, E (Avci, Emin) [4] ; Aydemir, Ö (Aydemir, Omer) [4]

 (provided by Clarivate) 

Source

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY

Volume

58

Issue

1

Page

41-47

DOI

10.29399/npa.25056

Published

MAR 2021

Indexed

2021-05-23

Document Type

Article

Abstract

Introduction: Even though an increase in the number of hospital admissions for manic and depressive periods at certain times of the year is reported in bipolar disorder (BD), mood symptoms do not show a seasonal variation. We aimed to find out the possible causes of increased hospital admissions of BD patients in certain periods of the year.

Methods: The study was carried out in four centers in Turkey. The patient group consisted of 41 persons with a diagnosis of BD in remission. The healthy control (HC) group consists of 37 persons. The selected evaluation times are fall equinox (September 23), spring equinox (March 21), summer solstice (June 21) and winter solstice (December 21). For mood symptoms, Hamilton Depression Rating Scale and Young Mania Rating Scale; for functioning Functioning Assessment Short Test; for neurocognition Stroop Test (ST) and Rey Auditory Verbal Learning Test (RAVLT), for biological rhythm Biological Rhythms Interview of Assessment in Neuropsychiatry, and Seasonal Pattern Assessment Questionnaire were used.

Results: In terms of mood symptoms no seasonal variation was found. Across all four periods of assessment of BD group, statistically significant variation was only observed in the instant recall, learning and recognition domains of RAVLT and word test and color test domains of ST; however, it was not sufficient to distinguish the BD group separating from the control group.

Conclusions: In terms of mood symptoms, psychosocial functionality, biological rhythm, neurocognition, no seasonal variation was demonstrated that could distinguish the BD group from the HC group.

Keywords

Author Keywords

Biological rhythm bipolar disorder neurocognition psychosocial functionality seasonality

The Assessment of Cognitive Dysfunction in Major Depressive Disorder: A 16-Week Prospective Case-Control Study

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Özkan, HM (Ozkan, Huseyin Murat) [2] ; Sücüllüoglu-Dikici, D (Suculluoglu-Dikici, Didem) [1] ; Asçibasi, K (Ascibasi, Kadir) [3] ; Alçi, D (Alci, Deniz) [4] ; Altunsoy, N (Altunsoy, Neslihan) [5] ; Kuru, E (Kuru, Erkan) [5] ; Yüzeren, S (Yuzeren, Serra) [6] ; Aydemir, O (Aydemir, Omer) [7]

 (provided by Clarivate) 

Source

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY

Volume

31

Issue

1

Page

25-33

DOI

10.5152/pcp.2021.20148

Published

MAR 2021

Indexed

2021-05-06

Document Type

Article

Abstract

Objective: Cognitive dysfunction is one of the core components of major depressive disorder (MDD). It is estimated that two-thirds of patients diagnosed with MDD have cognitive deficits. Cognitive symptoms are pervasive and affect functioning in several domains. This 16-week prospective case-control study aimed to assess the change of mood and cognitive symptoms during treatment.

Materials and Methods: Ninety-eight patients with MDD and 113 healthy controls (HCs) participated in the study. The MDD group was evaluated 6 times (baseline, 2nd, 4th, 8th, 12th, and 16th weeks). For mood symptoms, the Montgomery-Asberg Depression Rating Scale was used, and for neurocognitive functions, the Perceived Deficits Questionnaire-Depression was used, and the Digit Symbol Substitution Test was administered to both groups.

Results: At baseline, compared with the HCs, the neurocognitive function of patients with MDD was worse. From the 8th to the 16th week assessments, in both neurocognitive tests, the cognitive functions of patients with MDD had improved. Despite this improvement and the patients achieving remission, the patients' cognitive performance did not improve to the level of the HC group at the 16th week.

Conclusion: Our longitudinal research revealed that even though mood symptoms decreased and patients with depression did achieve symptomatic remission, their cognitive deficits perpetuated.

Keywords

Author Keywords

Cognition cognitive dysfunction depression major depressive disorder neurocognitive function

The evaluation of metacognitive beliefs and emotion recognition in panic disorder and generalized anxiety disorder: effects on symptoms and comparison with healthy control

By

Aydin, O (Aydin, Orkun) [1] ; Balikçi, K (Balikci, Kuzeymen) [2] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [3] ; Aydin, PÜ (Aydin, Pinar Unal) [1]

 (provided by Clarivate) 

Source

NORDIC JOURNAL OF PSYCHIATRY

Volume

73

Issue

4-5

Page

293-301

DOI

10.1080/08039488.2019.1623317

Published

JUL 4 2019

Early Access

JUN 2019

Indexed

2019-10-16

Document Type

Article

Jump to

Abstract

Background: The impairments in metacognitive functions and emotion recognition are considered as liable factors in anxiety disorders. Aims: The better understanding of these cognitive abilities might lead to develop more accurate treatment methods for patients who suffer from anxiety. Methods: Forty-four patients with panic disorder (PD), 37 individuals with generalized anxiety disorder (GAD) and 44 healthy control (HC) were participated in our study. Metacognition questionnaire-30 (MCQ-30), Reading The Mind From The Eyes Test and symptom severity tests were administered. Results: Statistical analyses estimated the dysfunctional metacognitive beliefs and disrupted emotion recognition in patients relative to HC. The 'need to control thoughts' aspect of metacognitive beliefs was accounted for symptom severity in GAD. Improper metacognitive beliefs were significantly predicted the PD and GAD. In addition, impoverished emotion recognition predicted the GAD. Conclusions: Our study revealed the role of inconvenient metacognitive beliefs and distorted emotion recognition in PD and GAD. These findings might facilitate the treatment management in cognitive therapies of anxiety disorders via pointing out more reasonable targets across improper cognitive fields.

Keywords

Author Keywords

Metacognitive beliefs metacognition emotion recognition panic disorder generalized anxiety

The evaluation of metacognitive beliefs and emotion recognition in panic disorder and generalized anxiety disorder: effects on symptoms and comparison with healthy control

By

Aydin, O (Aydin, Orkun) [1] ; Balikçi, K (Balikci, Kuzeymen) [2] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [3] ; Aydin, PÜ (Aydin, Pinar Unal) [1]

 (provided by Clarivate) 

Source

NORDIC JOURNAL OF PSYCHIATRY

Volume

73

Issue

4-5

Page

293-301

DOI

10.1080/08039488.2019.1623317

Published

JUL 4 2019

Early Access

JUN 2019

Indexed

2019-10-16

Document Type

Article

Jump to

Abstract

Background: The impairments in metacognitive functions and emotion recognition are considered as liable factors in anxiety disorders. Aims: The better understanding of these cognitive abilities might lead to develop more accurate treatment methods for patients who suffer from anxiety. Methods: Forty-four patients with panic disorder (PD), 37 individuals with generalized anxiety disorder (GAD) and 44 healthy control (HC) were participated in our study. Metacognition questionnaire-30 (MCQ-30), Reading The Mind From The Eyes Test and symptom severity tests were administered. Results: Statistical analyses estimated the dysfunctional metacognitive beliefs and disrupted emotion recognition in patients relative to HC. The 'need to control thoughts' aspect of metacognitive beliefs was accounted for symptom severity in GAD. Improper metacognitive beliefs were significantly predicted the PD and GAD. In addition, impoverished emotion recognition predicted the GAD. Conclusions: Our study revealed the role of inconvenient metacognitive beliefs and distorted emotion recognition in PD and GAD. These findings might facilitate the treatment management in cognitive therapies of anxiety disorders via pointing out more reasonable targets across improper cognitive fields.

Keywords

Author Keywords

Metacognitive beliefsmetacognitionemotion recognitionpanic disordergeneralized anxiety

Keywords

Author Keywords

OQESA emotional blunting antidepressants

Reliability and validity of Turkish Form of DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Scale-Adult Version

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Balikçi, K (Balikci, Kuzeymen) [2] ; Aydemir, O (Aydemir, Omer) [3]

Group Author

DSM-5 Olcek Calisma Grubu (DSM-5 Olcek Calisma Grubu)

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Page

5-12

Supplement

2

DOI

10.5455/apd.228806

Published

APR 2017

Indexed

2017-05-31

Document Type

Article

Abstract

Objective: The aim of this study is to demonstrate the reliability and validity of the Turkish Form of DSM-5 SelfRated Level 1 Cross-Cutting Symptom Scale Adult Version which is developed according to DSM-5 criteria to measure the severity of general symptomatology. Methods: This research was carried out with patients and their relatives who fulfilled the criteria of any psychiatric disorder according to DSM-5 criteria in inpatient and outpatient psychiatric clinics of Manisa Celal Bayar University, School of Medicine and healthy control group without any mental or physical disease. Accordingly, the distribution of psychiatric diagnosis of the patients were as follows: 39 patients with major depressive disorder, three patients with panic disorder, two patients with obsessive-compulsive disorder, four patients with schizophrenia, two patients with schizoaffective disorder, seven patients with BTA anxiety disorder, two patients with conversion disorder and post-traumatic stress disorder in one patient. Beside Level 1 Cross-Cutting Symptom Scale, the most widely used for general semptomatology self-rated scale, Symptom Check List-90-Revised Form (SCL-90-R) was used for concurrent validity. In reliability analysis internal consistency coefficient and item-total correlation analysis; in validity analyses exploratory factor analysis and correlation analysis with the SCL-90-R and subscales was performed for validation. Results: This research was carried out with 206 volunteers. 61.2% of the sample group (n= 126) were female and the mean age of the study group was 35.1 +/- 11.2 years. 29.6% of the group were college graduates, 36.4% primary school graduates, 7.8% middle school graduates and 23.3% were also high school. The internal consistency of the Level 1 Cross-Cutting Symptom Scale was 0.94 and, item-total score correlation coefficients of the Level 1 Cross-Cutting Symptom Scale were between 0.30-0.79. In the exploratory factor analysis, for sample adequacy Kaiser-Meier-Olkin (KMO) coefficient was calculated as 0.92 and Bartlett coefficient was 3007.76. Three-factor solution was obtained, representing 60.8% of the total variance. In the analysis of the correlation between the subscales of SCL-90-R and subscales of the Level 1 CrossCutting Symptom Scale were as follows; for depression r= 0.72, for anxiety r= 0.80, for somatization r= 0.72, for psychosis r= 0.70, for obsessive compulsive symptoms r= 0.68, for personality r= 0.72, for suicide r= 0.53, for sleep r= 0.76, for anger r= 0.64 and for the total score r= 0.87 was obtained. Conclusion: These findings show that the Level 1 Cross-Cutting Symptom Scale is reliable and valid for Turkish.

Keywords

Author Keywords

DSM-5 Cross-Cutting Symptom Scale reliability validity

Disease burden and associated factors in caregivers of patients with obsessive-compulsive disorder

By

Suculluoglu-Dikici, D (Suculluoglu-Dikici, Didem) [1] ; Cokmus, FP (Cokmus, Fikret Poyraz) [1] ; Akin, F (Akin, Funda) [2] ; Eser, E (Eser, Erhan) [3] ; Demet, MM (Demet, Mehmet Murat) [2]

 (provided by Clarivate) 

Source

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES

Volume

33

Issue

4

Page

421-428

DOI

10.14744/DAJPNS.2020.00110

Published

2020

Indexed

2021-02-03

Document Type

Article

Abstract

Objective: Obsessive-compulsive disorder (OCD) is one of the leading causes of disability and poor quality of life, with impairment in many areas. It can also adversely affect family members and friends that the person lives with, and this results in a burden. We aimed to evaluate the disease burden in caregivers of patients with OCD and the factors that negatively affect caregiver burden.

Method: The study population consisted of 94 patients with OCD and their caregivers. The Yale-Brown Obsessive-Compulsive Scale (YBOCS), the Hamilton Depression Rating Scale, and the World Health Organization Quality of Life Questionnaire Brief Form were filled out by the patients, and the Burden Assessment Scale (BAS) by the caregivers.

Results: Longer duration of treatment, higher YBOCS obsession and compulsion scores of the patients, and lower environmental quality of life dimension scores of the patients were found to increase the BAS scores of the caregivers. Additionally, these variables were found to be significant predictors for disease burden (BAS score) (p<0.05).

Conclusion: Our study revealed that many variables affect burden, even in caregivers who have no extra burden (who has no disease to cause a burden). Caregivers of patients with OCD should be included in the behavioral and pharmacologic treatment process for the benefit of both the OCD treatment management and the protection of family health.

Keywords

Author Keywords

Burden caregiver burden disease burden family burden obsessive compulsive disorder

 Evaluation of psychosocial functioning in the acute treatment term of major depressive disorder: A 16-week multi-centered follow-up study

By

Altunsoy, N (Altunsoy, Neslihan) [1] , [2] ; Dikici, DS (Dikici, Didem Suculluoglu) [3] ; Cökmüs, FP (Cokmus, Fikret Poyraz) [3] ; Özkan, HM (Ozkan, Huseyin Murat) [4] , [5] ; Ascibasi, K (Ascibasi, Kadir) [6] ; Alçi, D (Alci, Deniz) [7] ; Kuru, E (Kuru, Erkan) [1] ; Yüzeren, S (Yuzeren, Serra) [8] ; Aydemir, O (Aydemir, Omer) [9]

 (provided by Clarivate) 

Source

ASIAN JOURNAL OF PSYCHIATRY

Volume

66

DOI

10.1016/j.ajp.2021.102883

Article Number

102883

Published

DEC 2021

Early Access

OCT 2021

Indexed

2021-11-11

Document Type

Article

Abstract

Objective: Major depressive disorder is the leading cause of non-fatal burden, and disability in adulthood. Even though depression is well-treated in the acute term,psychosocial functioning does not get back to the premorbid level most of the time. In this present study, it is aimed to evaluate the outcome of the acute term treatment of major depressive disorder in terms of psychosocial functioning.

Methods: The study is an open-label, observational, multi-center follow-up study for four months of patients with major depressive disorder according to DSM-5. Patients were evaluated with Montgomery Asberg Depression Rating Scale (MADRS), Sheehan Disability Scale (SDS) and Short Form-36 (SF-36) at the beginning, and at the 2., 4., 8., 12. and 16.weeks.

Results: 100 patients were invited to the study and 56 patients completed the study.As a result of the treatment, the mean MADRS and SDS scores decreased significantly. All domains of SF-36 were improved significantly with the treatment. Unfortunately patients suffering from MDD could not reach the normative data,especially on the domains of social functioning, role emotional, pain, and general health perception. Treatment outcomes show that SNRI users presented higher scores on the domains of pain and physical functioning. However SSRI users showed better outcomes on the domains of mental health and vitality.

Conclusion: Our research corroborated that even patients gain symptomatic remission in MDD treatment, psychosocial dysfunction persists. It is also concluded that different antidepressant options may act differently on treatment outcomes.

Keywords

Author Keywords

Antidepressive agents Depression  Depressive disorder Psychosocial functioning Quality of life

Reliability and validity of Turkish Form of Severity of Acute Stress Symptoms Scale

By

Asçibasi, K (Ascibasi, Kadir) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Aydemir, Ö (Aydemir, Omer) [3]

Group Author

DSM-5 Olcek Calisma Grubu (DSM-5 Olcek Calisma Grubu)

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Page

38-44

Supplement

2

DOI

10.5455/apd.237985

Published

APR 2017

Indexed

2017-05-31

Document Type

Article

Abstract

Objective: This study demonstrates the reliability and validity of the Turkish Form of Acute Stress Symptoms Scale which was developed according to DSM-5 criteria to measure the severity of acute stress disorder. Methods: This research was carried out with the patients who fulfilled the criteria of any stress related disorders according to DSM5 criterion in inpatient and outpatient psychiatric clinics of Celal Bayar University, School of Medicine. Except for acute or post-traumatic stress disorders, patients with any other mental or physical disease were excluded. Fifty patients were included in the study. As the control group, 150 volunteers without any mental or physical diseases were invited. Beside Acute Stress Symptoms Scale, Peritraumatic Dissociative Experiences Questionnaire (PDEQ) which is the most commonly used self-rated instrument to rate the experience of recent trauma is utilized for concurrent validity. In reliability analyses, internal consistency coefficient and item-total correlation coefficients were calculated. In validity analyses, factor analysis and correlation analysis with PDEQ were performed. Results: The mean age of the study group was 32.1 +/- 12.0 years, and 57.7% of the sample group (n= 116) were female. 31.3% of the group were college graduates, 36.3% primary school graduates, 29.9% is high school graduates. Disease duration in acute stress disorder group was 4.08 +/- 4.57 years. For the internal consistency of Acute Stress Symptoms Severity Scale, Cronbach's alpha coefficient was found to be 0.95. Item-total score correlation coefficients were between 0.76 and 0.88 and all were statistically significant. For the exploratory factor analysis, sample adequacy was tested, Kaiser-Meier-Olkin (KMO) coefficients was 0.91 and Bartlett coefficient was 1388. Single-factor solution was obtained and the eigenvalue was 5.40, representing 77.8% of the total variance. Factor loadings of the items were between 0.82-0.92. The coefficient of correlation analysis with PDEQ was calculated as r= 0.88. Area under the curve is found 0.99 as the result of ROC analysis. Conclusion: With these findings, it is shown that the severity of Acute Stress Symptoms Scale is reliable and valid for Turkish.

Keywords

Author Keywords

severity of acute stress symptoms scale validity reliability

Evaluation of serum MicroRNA expression profiles in patients with panic disorder

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Özmen, E (Ozmen, Erol) [2] ; Alkin, T (Alkin, Tunc) [3] ; Batir, MB (Batir, Muhammet Burak) [4] ; Çam, FS (Cam, Fethi Sirri) [4]

 (provided by Clarivate) 

Source

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY

Volume

29

Issue

1

Page

8-13

DOI

10.1080/24750573.2018.1429844

Published

JAN 2 2019

Indexed

2019-03-28

Document Type

Article

Abstract

BACKGROUND: Studies on the role of microRNAs (miRNA) in anxiety disorders are limited. We aimed to determine the availability of miRNAs as biomarkers in serum and to demonstrate the changes of miRNAs expression in patients with panic disorder (PD). METHODS: Thirty-five patients with PD and 35 healthy controls (HC) were evaluated with Structured Clinical Interview for DSM Disorders-I (SCID-I) and Panic Disorder Severity Scale (PDSS). In each group miRNA expression analysis was performed in venous blood by the Real-time Polymerase Chain Reaction (RT-PCR) method for genetic evaluation. RESULTS: Compared with the HC group, eight miRNA expression levels were found different in the PD group. Five of them were upregulated and three of them were downregulated. There was no correlation between the levels of miRNA expression with PDSS total score and PDSS sub-items. However, miR-1297 and miR-4465 expression levels were significantly different between the two groups. LIMITATIONS: There are some limitations in this research. Firstly the number of samples is small. Another limitation of our study is that the presence of medical illness and continuous drug use were not excluded when PD and HC groups were selected. CONCLUSIONS: Our research is the first miRNA expression study in patients with PD which excluded psychotropic use and additional psychiatric disorders. In the PD group, miR-1297 and miR-4465 expression was upregulated than compared to the HC group. miR-1297 and miR-4465 regulate the GABAA gene regions that affect GABA(A) receptor subtypes that thought to play a role in the aetiology of PD.

Keywords

Author Keywords

Anxiety epigenetic miR-1297miR-4465 panic disorder

Relationship of levetiracetam and obsessive-compulsive disorder: a case report

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Asçibasi, K (Ascibasi, Kadir) [2] ; Öztekin, S (Oztekin, Signem) [3] ; Demet, MM (Demet, Mehmet Murat) [4]

 (provided by Clarivate) 

Source

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY

Volume

27

Issue

3

Page

325-327

DOI

10.1080/24750573.2017.1342798

Published

2017

Indexed

2017-12-11

Document Type

Article

Abstract

Levetiracetam has gained wide acceptance in the treatment of epilepsy due to its broad-spectrum efficacy, the lack of significant drug-drug interactions, and a relatively benign side effect profile. However, in recent years, the treatment of epilepsy using levetiracetam has been associated with psychiatric side effects such as anxiety, irritability, hostility, depression, hallucinations, and, in some rare cases, obsessive-compulsive disorder. In this case report, we present and discuss onset of obsessive-compulsive disorder symptoms in a 55-year-old epileptic female patient, who did not have any previous psychiatric disorder, including obsessive-compulsive disorder, and who received levetiracetam treatment.

Keywords

Author Keywords

Epilepsy levetiracetam obsessive-compulsive disorder

Quality of Life and Associated Risk Factors in Caregivers of Patients with Obsessive Compulsive Disorder

By

Dikici, DS (Dikici, Didem Suculluoglu) [1] ; Eser, E (Eser, Erhan) [2] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [3] ; Demet, MM (Demet, Mehmet Murat) [4]

 (provided by Clarivate) 

Source

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY

Volume

29

Issue

4

Page

579-586

DOI

10.1080/24750573.2018.1496524

Published

OCT 2 2019

Indexed

2020-02-10

Document Type

Article

Abstract

INTRODUCTION: Obsessive compulsive disorder (OCD) is a chronic disease that affects social relationships, and occupational and academic performance of patients and their relatives due to cognitive, emotional, and behavioural aspects of the disease. Quality of life (QoL) in relatives of patients with OCD has previously been reported and compared with caregivers of patients with other psychiatric conditions. However, there are few studies available in the literature regarding the causality of QoL in caregivers of patients with OCD.

OBJECTIVE: The aim of this study was to evaluate QoL of caregivers of patients with OCD and predictors of QoL of the family caregivers.

METHODS: The study population comprised of 68 patients with OCD and their caregivers. The dependent variable of this study is "QoL of caregivers" as assessed by the short version of the World Health Organization Quality of Life questionnaire (WHOQOL-BREF-TR). The Structured Clinical Interview for DSM-IV/Clinical Version (SCID-I/CV), Yale-Brown obsessive-compulsive scale (Y-BOCS), Y-BOCS symptom checklist, Hamilton Depression Rating Scale (HAM-D), and WHOQOL-BREF-TR were completed by the patients, whereas the SCID-I/CV, WHOQOL-BREF-TR, and Burden Assessment Scale (BAS) were completed by the caregivers. Student's t-test, MWU, ANOVA, Kruskal-Wallis ANOVA, and Spearman's correlations were used in univariate analyses, and multiple linear regression tests were run in multivariate analyses. Critical VIF values were taken as 5.0 for detecting collinearity among independent variables in the regression analyses. Type 1 error was taken as 0.05 in the analyses.

RESULTS: Linear regression analysis showed that caregivers' sex, education level, occupational status, disease burden, and patients' sex, physical QoL, and disease severity were predictors of caregivers' QoL. Moreover, disease burden was the only common predictor that affected all four dimensions (physical, psychological, social relations, environmental) of the caregiver's QoL, and as the perceived disease burden increased, the caregiver's QoL deteriorated.

Keywords

Author Keywords

Burden caregivers  caregiver burden quality of life obsessive compulsive disorder

Psychometric properties of the Turkish Versions of Perceived Deficit Questionnaire - Depression and British Columbia Cognitive Complaints Inventory

By

Aydemir, Ö (Aydemir, Omer) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Akdeniz, F (Akdeniz, Fatma) [2] ; Sücüllüoglu Dikici, D (Suculluoglu Dikici, Didem) [3] ; Balikçi, K (Balikci, Kuzeymen) [3]

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Issue

3

Page

224-230

DOI

10.5455/apd.228537

Published

JUN 2017

Indexed

2017-07-14

Document Type

Article

Abstract

Objective: In major depressive disorder, both during acute episode and in remission neurocognitive symptoms endure, but are underrated. The aim of this study is to demonstrate reliability and validity of the Turkish versions of Perceived Deficit Questionnaire-Depression (PDQ-D) and British Columbia Cognitive Complaints Inventory (BC-CCI) which are useful in the subjective assessment of neurocognitive symptoms in major depressive disorder. Methods: Turkish forms of the instruments are obtained after the translation and back-translation procedure. Thereafter, 50 in-or outpatients diagnosed with major depressive disorder, and 150 healthy volunteers for conducting the factor analyses and 68 healthy age- and education-matched controls for performing the group comparisons were included in the study. Beside the study instruments, Digital Symbol Substitution Test (DSST) used in the objective assessment of neurocognitive symptoms is applied. Results: The mean age of major depressive disorder group (n=50) was 37.5 +/- 11.4 and of healthy control group for the factor analyses was 23.4 +/- 5.5 and of that for the group comparisons was 35.4 +/- 9.9. Cronbach alpha coefficient of BC-CCI was 0.93 and item-total score correlation coefficients were between 0.69-0.85. Cronbach alpha coefficient of PDQ-D was 0.96 and item-total score correlation coefficients were between 0.52-0.91. In the factor analysis of both instruments, one factor solution was obtained. The correlation between BC-CCI and DSST was r=0.40, and for PDQ-D it was r=0.41. Both BC-CCI and PDQ-D significantly differentiated major depressive disorder group from healthy control groups. Conclusion: These results suggest that the Turkish forms of Perceived Deficit Questionnaire-Depression (PDQ-D) and British Columbia Cognitive Complaints Inventory (BC-CCI) are practical in the assessment of neurocognitive symptoms of major depressive disorder and can be used reliably and validly both in studies and in daily practice.

Keywords

Author Keywords

depression neurocognitive symptoms Perceived Deficit Questionnaire Depression British

Quickly diagnosed and treated prepubertal Type 1 narcolepsy case

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Aydin, O (Aydin, Orkun) [2] ; Dikici, DS (Dikici, Didem Suculluoglu) [3] ; Sapmaz, SY (Sapmaz, Sermin Yalin) [4]

 (provided by Clarivate) 

Source

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY

Volume

28

Issue

2

Page

227-229

DOI

10.1080/24750573.2017.1408230

Published

2018

Indexed

2018-01-01

Document Type

Editorial Material

Abstract

Excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucination are the classic tetrad of narcolepsy. It has been shown that narcolepsy, a chronic and disabling disease, starts in childhood and adolescence rather than adulthood. The International Classification of Sleep Disorder (ICSD-3) classifies narcolepsy into Type 1 (narcolepsy with cataplexy) and Type 2 (narcolepsy without cataplexy). There is low awareness and knowledge of narcolepsy among the general public, primary care physicians, and sleep specialists. It has been shown that the lack of recognition of disease symptoms delayed the diagnosis of narcolepsy from 8.7 to 22.1 years. In this case report, we will discuss the case of Type 1 narcolepsy, which started in the prepubertal period and was diagnosed and treated in a short period of time.

Keywords

Author Keywords

Cataplexy narcolepsy prepubertal sleep disorders

Psychotic disorder secondary to systemic corticosteroids

By

Çökmüs, FP (Cokmus, Fikret Poyraz) [1] ; Asçibasi, K (Ascibasi, Kadir) [1] ; Sarikavak, T (Sarikavak, Talat) [1] ; Özmen, E (Ozmen, Erol) [1]

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

17

Issue

1

Page

74-76

DOI

10.5455/apd.175455

Published

2016

Indexed

2016-04-06

Document Type

Article

Abstract

The discovery of corticosteroids in 1949, revolutionized the practise of medicine. Corticosteroids become the mainstay of therapy for a variety of acute and chronic diseases (e.g., endocrinopathies, cancer, inflammatory diseases, systemical lupus erythematosus, multiple sklerosis, and asthma). Corticosteroids often induce psychiatric syndromes, including depression, mania, psychosis, delirium, obsessive-compulsive symptoms, suicidality, catatonia and reversible dementia(1). In our case, we will discuss 67 years old male patient who developed psychotic disorder after receiving systemic corticosteroid treatment.

Keywords

Author Keywords

jealousy delusion neuropsychiatric side effect systemic corticosteroid

Attitudes of Resident Physicians Working in a University Hospital Towards Schizophrenia

By

Taskin, EO (Taskin, Emin Oryal) [1] ; Ascibasi, K (Ascibasi, Kadir) [2] ; Cokmus, FP (Cokmus, Fikret Poyraz) [3] ; Özmen, E (Ozmen, Erol) [1]

 (provided by Clarivate) 

Source

PSYCHIATRY AND BEHAVIORAL SCIENCES

Volume

9

Issue

4

Page

147-157

DOI

10.5455/PBS.20190513032606

Published

2019

Indexed

2019-01-01

Document Type

Article

Abstract

Objective: To evaluate the attitudes of resident physicians working in a university hospital (future specialists) towards schizophrenia.

Methods: The data of 170 resident physicians who completed the questionnaires in full were included in the research. The data collection procedure was completed in 6 months by two resident psychiatrists using the sealed envelope method for the questionnaires (an 11-item socio-demographic and an 8-item professional information form and a 32-item attitude towards schizophrenia survey that was prepared by the Psychiatric Research and Training Center). The effect of the sociodemographic and occupational variables on the responses to the questionnaire items was tested using logistic regression analysis.

Results: The mean age of the participants was 28.07 +/- 2.40 (min=24-max=42) years. Approximately 98.8% (n=168) described schizophrenia as a 'disorder' and 78.2% (n=133) as a 'psychiatric disorder.' Some 64.1% (n=109) of the participants stated that schizophrenia was a congenital disease, 81.2% (n=138) said it was a curable disease, 85.9% (n=145) though that it could be treated with medication, 60% (n=102) believed that the medications used for treating schizophrenia would cause dependence, and 81.8% (n=139) stated that the medications used would involve serious adverse effects. Nearly 70.6% (n=120) of the participants stated that they could work with someone with schizophrenia and 45.9% (n=78) said that they could marry someone with schizophrenia. The presence of psychiatric diagnoses in a close friend (social acceptance of patients) was found to be an influential variable.

Conclusions: The resident physicians had high-level knowledge of schizophrenia as a psychiatric disorder, but their knowledge on the effects and adverse effects of the medication was insufficient or incorrect. The sample's social acceptance of patients was generally good, despite putting social distance in situations requiring more personal intimacy. Based on these results, to treat schizophrenia more successfully, we need to either revise psychiatry curriculum in medical education or provide targeted skill training for non-psychiatric physicians in order to adopt more positive attitudes towards patients with schizophrenia and refer them appropriately to psychiatrists when needed.

Keywords

Author Keywords

Attitude non-psychiatric physicians resident physicians schizophrenia stigma

2Relationship between childhood trauma and aggression in bipolar disorder

By

Aydin, O (Aydin, Orkun) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Balikçi, K (Balikci, Kuzeymen) [3] ; Aydin, PU (Aydin, Pinar Unal) [1] ; Danaci, AE (Danaci, Aysen Esen) [4]

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

19

Issue

3

Page

274-280

DOI

10.5455/apd.276919

Published

2018

Indexed

2018-11-02

Document Type

Article

Abstract

Objective: This research was conducted to define the relationship of childhood trauma and aggression in bipolar disorder. Methods: This study was conducted between December 2015 and March 2016 in Manisa Mental Health Diseases Hospital. The study population consisted of 449 patients. The minimum sample size of the universe is calculated 209 with 95% confidence interval and 5% standard deviation using the known formula. The data, is collected using Information Form, Childhood Trauma Questionnaire (CTQ-28), Buss-Durkee, and the Aggression Scale. The data was evaluated by number, percentage, t test, one-way analysis of variance, Mann-Whitney, Kruskal-Wallis and the Pearson's correlation coefficient in SPSS 22.0 program. Results: The average age of the patients is 34.71 +/- 11.16 (range: 18-65). 61.7% of the patients are male, 50.2% of patients are single, 34.0% of patients are primary school graduates. Income status of patients; 48.8% of patients the income is less than expenses. Socio-demographic characteristics such as the income situation of the patient, marital status, education level, parents' education, place of residence, immigration status, self-harm state with childhood trauma scale total score and Buss-Durkee Aggression Scale was found a statistically significant correlation between subdomains. Conclusion: Our results are suggest that there can a relationship between childhood trauma and aggression levels in bipolar disorder.

Keywords

Author Keywords

bipolar disorder trauma child abuse aggression psychiatric nursing

Validity and reliability of the Turkish Version of the Clinician Rated Severity of Autism Spectrum and Social Communication Disorders Scale

By

Aydin, O (Aydin, Orkun) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Aydemir, Ö (Aydemir, Omer) [3]

Group Author

DSM-5 Olcek Calisma Grubu (DSM-5 Olcek Calisma Grubu)

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Page

92-98

Supplement

2

DOI

10.5455/apd.240415

Published

APR 2017

Indexed

2017-05-31

Document Type

Article

Abstract

Objective: The purpose of the present study was to investigate the validity and reliability of the Turkish form of the Clinician Rated Severity of Autism Spectrum and Social Communication Disorders Scale. The scale was originally developed to measure the severity of autism spectrum and social communication disorders regarding the DSM-5 criteria. Methods: The study was conducted in the Department of Psychiatry at Celal Bayar University Hospital. The participants were in- or out-patients diagnosed with any psychotic disorders according to DSM-5. The exclusion criteria were comorbidity of other psychiatric disorders and/or physical diseases. The study was carried out with a total of 49 patients who were diagnosed with schizophrenia (n=40), schizoaffective disorder (n=3), and not otherwise specified psychotic disorder (n=3). One hundred and one volunteers without any mental or physical disease were also included to represent the healthy control. Reliability analysis was performed to examine the internal consistency of the Turkish version of the scale. Additionally, item-total correlations were reported. In validity analyses, comparison of the total score of the scale in the patient and control groups was evaluated for the discriminative validity. ROC analysis was also performed. Results: 52.7% of the sample were male (n=79). 69.3% of them were graduated from university (n=104), 19.3% from high school (n=29), and 8% from elementary school (n=12). The mean age of the study group was 26.3 +/- 10.3 years. Disease duration of psychotic disorder group was 18,29 +/- 6.43 years. The internal consistency of the Autism Spectrum and Social Communication Disorder Scale was 0.81. Furthermore, item-total correlations revealed that all items in the scale contributed to the consistency of scores with item-total correlations approaching 0.70. The mean score of the scale in the patient group on the scale was 1.42 whereas the mean score of the healthy group was 0.0. The t-test analysis indicated that there was a statistically significant difference between the sample group and the healthy group in their scores on the scale. In the ROC analysis, the area under the curve was 0.84. Conclusion: Results demonstrated that the Turkish version of Autism Spectrum and Social Communication Disorder Scale was a valid and reliable instrument which may serve as useful in guiding future research that aims to understand autism spectrum and social communication disorder.

Keywords

Author Keywords

DSM-5 Turkish Version of Clinician Rated Severity of Autism Spectrum and Social Communication

The comparison of executive functions, social cognition and plasma oxytocin level between mothers' of schizophrenia patients and healthy control: searching for a new endophenotype

By

Aydin, O; Balikçi, K; Danaci, AE

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Issue

4

Page

307-313

DOI

10.5455/apd.248170

Published

AUG 2017

Document Type

Article

Abstract

Objective: Previous studies documented that there were a variety of endophenotypes that helped to diagnose as well as to predict functionality and treatment response. There is little, if any research that focused on investigating biochemical endophenotypes. Besides, the studies that include executive functions and social cognition, which were accepted as endophenotypes, have different results. In studies involving schizophrenia patients, the deficiency of oxytocin was found to be the most important hormone that would affect the treatment process. However, there have been no endophenotype studies that investigated the role of oxytocin hormone in the treatment process of schizophrenia patients. The purpose of the present study was twofold: (a) to detect new endophenotypes, and (b) to test endophenotypes that were previously found by focusing on the schizophrenia patients' mothers. Methods: The participants were the healthy mothers of schizophrenia patients and healthy control group. They took the Reading the Mind in the Eyes Test, Wisconsin Card Sorting Test, and Wechsler Adult Intelligence Scale vocabulary subtest, respectively. In addition, participants' blood samples were collected to include the level of plasma oxytocin as a biochemical in the data analyses. Results: Results revealed that there was a significant difference in plasma oxytocin levels for the healthy mother's of schizophrenia patients and the healthy control group. Low level of plasma oxytocin level was found to be the only significant factor that differentiates the patients' mothers and the healty control group. When the results of the Reading the Mind in the Eyes Test that measures executive functions, and the Wisconsin Card Sorting Test that measures social cognition were analyzed, no significant differences were found between the groups. Discussion: Our findings showed that oxytocin hormone could be a new endophenotype for schizophrenia. However, there is still a need for studies that focus on the investigation of detecting new endophenotypes.

Keywords

Author Keywords

schizophrenia endophenotype caregiver oxytocin social cognition executive function

Reliability and validity of Turkish Form of Level 2 Anxiety Scale

By

Aydin Asik, E (Aydin Asik, Ecenur) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Aydemir, Ö (Aydemir, Omer) [1]

Group Author

DSM-5 Olcek Calisma Grubu (DSM-5 Olcek Calisma Grubu)

 (provided by Clarivate) 

Source

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY

Volume

18

Page

45-50

Supplement

2

DOI

10.5455/apd.240513

Published

APR 2017

Indexed

2017-05-31

Document Type

Article

Abstract

Objective: This study aims to demonstrate the reliability and validity of the Turkish Form of Level 2 Anxiety Scale developed according to DSM-5 criteria to measure the severity of panic disorder. Methods: This study was carried out with patients with a diagnosis of any anxiety disorder according to DSM-5 criteria who are under treatment in Celal Bayar University Faculty of Medicine Psychiatry inpatient or outpatient clinics. Patients with any mental or physical disease except for anxiety disorders were excluded. Accordingly, 54 patients with anxiety disorder were included in the study and these were distributed as panic disorder in seven patients, generalized anxiety disorder in two patients, agoraphobia in three patients, specific phobia in one patient, obsessive-compulsive disorder in two patients, somatization disorder in one patient and not otherwise specified anxiety disorder in 38 patients. As the healthy control group in 104 volunteers without any mental or physical disease were included. Beside Level 2 Anxiety Scale the most widely used self-rated scale, Spielberger's State-Trait Anxiety Inventory was used for concurrent validity. In reliability analysis internal consistency coefficient and item-total correlation analysis; in validity analyses factor analysis and correlation analysis with the Spearman Correlation Analysis (SCA) was performed for validation. Results: The mean age of the study group was 28.23 +/- 11.7 years and 58.9% of the sample group (n=93) were female. 64.6% of the group were college graduates, 19.0% primary school graduates, 12.7% is also high school graduates. Disease duration of anxiety disorder group was 17.2 +/- 11.2 years. The internal consistency of the Level 2 Anxiety Scale was 0.94 and, item-total correlation coefficients of the Level 2 Anxiety Scale were between 0.68 and 0.88. In the exploratory factor analysis, for sample adequacy Kaiser-Meier-Olkin (KMO) coefficient was calculated as 0.90 and Bartlett coefficient was 1.08. Single-factor solution was obtained and the eigenvalue was 5.26, explaining 75.2% of the total variance. Factor loadings of the items were between 0.75 and 0.92. Coefficient of correlation analysis with SCA was calculated as r=0.45. Conclusion: These findings have been shown that the Level 2 Anxiety Scale is reliable and valid for Turkish.

Keywords

Author Keywords

Level 2 Anxiety Scale in DSM-5reliability validity

The problematic use of social networking sites associates with elevated symptoms in patients with major depressive disorder

By

Aydin, O (Aydin, Orkun) [1] ; Çökmüs, FP (Cokmus, Fikret Poyraz) [2] ; Balikçi, K (Balikci, Kuzeymen) [3] ; Sücüllüoglu-Dikici, D (Suculluoglu-Dikici, Didem) [2] ; Ünal-Aydin, P (Unal-Aydin, Pinar) [1]

 (provided by Clarivate) 

Source

INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY

Volume

66

Issue

5

Page

496-503

DOI

10.1177/0020764020919791

Article Number

0020764020919791

Published

AUG 2020

Early Access

MAY 2020

Indexed

2020-05-27

Document Type

Article

Jump to

Abstract

Background:

Although excessive use of social networking site (SNS) is related to undesired effects on healthy individual's psychological well-being, there is a huge gap in studies performed with individuals who suffer from various mental disorders.

Aim:

The main goal of this study is to examine the association between problematic utilization of SNSs and depressive symptoms across patients diagnosed with major depressive disorder (MDD).

Methods:

111 patients diagnosed with MDD (diagnoses confirmed via the Structured Clinical Interview for DSM-5-Clinician Version (SCID-5/CV)) and 108 healthy controls (HCs) were recruited for the study. Montgomery-Asberg Depression Rating Scale (MADRS) and Bergen Social Media Addiction Scale (BSMAS) were administered by both MDD and HC groups. Group comparisons were estimated with multivariate analysis of covariance (MANCOVA) analyses. To identify the relationship between SNS addiction and depressive symptoms, the Pearson correlations were performed, and finally, we computed the multiple linear regression analyses to determine whether SNS addiction predicts depressive symptoms.

Results:

The results revealed that MDD group is more addicted to SNS relative to HC. In addition, depressive symptoms were significantly predicted by 'relapse' subdimension and the overall score of SNS addiction in the MDD group.

Conclusion:

Our study illustrated the detrimental effects of excessive SNSs usage on depressive symptoms in MDD particularly for the individuals in 'relapse' state of SNS addiction. The mental health workers should consider the usage patterns of SNSs in patients diagnosed with MDD during their clinical observation and management.

2014 – …                      Türkiye Psikiyatri Derneği, Genetik Çalışma Birimi Üyeliği

2014 - …                       Türkiye Psikiyatri Derneği, Anksiyete Çalışma Birimi Üyeliği

2015 - 2016                  Türkiye Psikiyatri Derneği, Manisa Şubesi Sekreterliği

2016 - …                       EPA Üyesi

2016- …                        ECNP üyeliği    

2018- …                        Türkiye Psikiyatri Derneği, Nörobilim Çalışma Birimi Üyeliği

2019-…                        Türkiye Psikiyatri Derneği, Genç Psikiyatristler Birimi Yönetim Kurulu Üyesi